Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Eisai Company Limited
sales of 539.10 billion Japanese Yen [US$4.82 billion]
of which 54%
was Pharmaceutical Business -Japan),
Astellas Pharma Incorporated
(1.31 trillion Japanese Yen [US$11.73 billion]
of which 58%
was Other), and
Daiichi Sankyo Company Limited
(955.12 billion Japanese Yen [US$8.54 billion]
of which 93%
was prescription drugs).
Takeda Pharmaceutical Company Limited reported sales of ¥1.73 trillion (US$15.48 billion)
March of 2017.
decrease of 4.2%
versus 2016, when the company's sales were ¥1.81 trillion.
Contributing to the drop in overall sales was the 4.8% decline
in Pharmaceutical Business, from ¥1.65 trillion to ¥1.57 trillion.
However, these declines were partially offset by the increase in sales of
Healthcare (up 3.1% to ¥82.57 billion)
Other (up 2.5% to ¥80.61 billion)